Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease.

Abstract

To evaluate changes in choroidal blood flow in patients with Vogt-Koyanagi-Harada (VKH) disease after initiation of corticosteroid treatment. Fourteen patients (10 men and 4 women) with acute VKH disease followed for 2years were retrospectively reviewed; only right eyes were included in the analysis. Mean blur rate (MBR) in the macula was measured by laser speckle flowgraphy (LSFG) and central choroidal thickness (CCT) was measured by optical coherence tomography (OCT), both prior to treatment and over 2years after initiation of corticosteroid treatment. Of 14 patients included in this study, 13 received initial treatment consisting of intravenous corticosteroid pulse therapy and one patient was treated using bilateral sub-Tenon injections of triamcinolone acetonide. Mean percentage change in MBR was significantly increased after initiation of treatment compared to pretreatment values (P < 0.001). Mean CCTs were significantly decreased after initiation of treatment, compared to pretreatment thicknesses (P < 0.001). There was no significant change in either MBR change or CCT at 1month after initiation of treatment through 2years of follow-up. The mean MBR percentage change was significantly higher in eyes with sunset glow fundus (SGF) compared to eyes without SGF at 1year. With initiation of corticosteroid treatment in VKH disease patients, choroidal blood flow improved and was maintained for 2years. However, the presence of SGF should be taken into consideration when interpreting MBR results in VKH disease patients.